Basal cell carcinoma is a malignant tumor that arises in the lower portion of the skin. It grows very slowly and almost never metastasizes, which defines its great prognosis. It usually arises in areas often exposed to the sun and appears as a shiny skin-colored, red or darker lesion.
Polygenic score
Influential genes: TP53,MC1R, SLC45A2
In BCC, TP53 mutations are one of the most common genetic changes and can lead to the development and progression of the disease.
Some of the MC1R variants may increase the risk of BCC. The risk is thought to be related to the gene's role in skin pigmentation and response to UV radiation.
The SLC45A2 gene is involved in pigmentation, and its variants have been associated with skin color and susceptibility to skin cancer.
Basal cell carcinoma, or BCC, is the most common cancer worldwide. It usually occurs on sun-exposed areas of your skin and can have various clinical presentations. The most important risk factor is sunlight exposure, others include age, personal and family history of BCC, immunosuppression, radiation therapy, arsenic exposure, etc. The definitive diagnosis can be made only after a biopsy. There are many treatment options available including surgery, topical medications, cryotherapy, laser therapy, etc. You can try preventing basal cell carcinoma development by avoiding the sun at peak hours and using sunscreen. BCC has an excellent prognosis when diagnosed and treated early.
Basal cell carcinoma is the most common cancer worldwide. In Europe, the estimated incidence is about 50 to 80 new patients per 100 000 persons per year.[1] Globally in 2019, there were 4 million cases. However, the incidence varies significantly across different countries and ages.
The main risk factor of BCC is sunlight exposure - particularly the exposure to harmful UV rays, including tanning beds. The damage you get from UV rays depends on several factors, like the overall lifetime exposure, intensity, and skin type. You are much more exposed to the sun if you live in a sunny or high-altitude location.
People with light skin that is easily freckled or sunburnt have a much higher rate of BCC development.
However, 20% of BCC arise in areas that aren't sun-exposed, so other risk factors also play a role.[2]
These include:
Basal Cell Carcinoma (BCC) usually develops sporadically but it can also be a result of Gorlin syndrome (also known as nevoid basal cell carcinoma syndrome), which is an autosomal dominant hereditary disorder (only one mutated allele can cause the disease). The key cause is considered to be the exposure to ultraviolet (UV) radiation, resulting in point mutations (usually represented by the C>T and CC>TT base transitions). BCC is known for its highest mutation rate among cancers, with over 65 mutations/Mbp (megabase pair). The genetic basis of sporadic BCC in the general population is still not fully uncovered.
Some tumor suppressor genes and proto-oncogenes (mutation of this gene leads to uncontrolled cell division) have been involved in BCC development, PTCH1 and SMO genes, the TP53 tumor suppressor gene, and also the members of the RAS proto-oncogene family.[3]
Often, those changes lead to loss-of-function mutations in the PTCH1 gene or activating mutations in the SMO gene. Whole-exome sequencing (WES) analyses have also discovered different affected genes and pathways, including MYCN, PPP6C, PTPN14, STK19, and LATS1 genes.[4-6]
Here in Macromo, polygenic risk scores are used to determine one's genetic risk. The polygenic risk score (PRS) is an estimate of the probability that an individual carries a given trait based on genetics, without considering environmental factors. Variants across their genome are summed and weighted according to their effect on the disease or trait.[7]
Basal cell carcinoma is usually found on sun-exposed areas, especially the face, ears, neck, scalp, chest, shoulders, and back. However, remember that it can also occur anywhere in the body, for example, on genitalia.
Five warning signs can suggest it is BCC:
However, basal cell carcinoma can look different than the above-described presentations. Sometimes it can resemble some non-cancerous skin conditions like psoriasis or eczema.
In people of color, the lesion can often be mistaken for moles since half of the lesions are brown.
Furthermore, basal cell carcinoma has a really low metastasizing potential, meaning it rarely spreads throughout the body. If you notice a suspicious lesion, you should consult your general practitioner or dermatologist.
An experienced doctor can make a diagnosis based on the clinical manifestation alone. The dermatologist can use a dermatoscope, a special visual aid device for skin conditions.
The definitive diagnosis is made upon a biopsy of the affected skin area. The doctor can take a small piece of tissue that will be examined under a microscope. In most cases a microscopic examination can be made after a full excision of the lesion.
Basal cell carcinoma is easily cured at its early stages. It's essential to treat it, so it doesn't lead to severe disfiguring complications.
There are several treatment options available:
Basal cell carcinoma might need additional treatment if cancer has spread throughout the body.[9]
Although BCC is the most common cancer worldwide, most cases are preventable.
You can take several precautions to minimize the risk of skin cancer development.[10]
BCC's prognosis depends on its potential risk of recurrence, which is related to the location, and clinical and histopathological (microscopic) findings.
Fortunately, most of the cases have an excellent prognosis.
If left untreated for a long time, basal cell carcinoma can grow and become disfiguring and dangerous. Rarely can it spread deep into the tissue and bone or even to distant organs.
If you once had BCC, it puts you at a higher risk of recurrence of this cancer and the development of another skin cancer, for example, melanoma. You should attend regular check ups to identify any new lesion as early as possible.
Get the guidelines for a healthier and longer life. With Macromo tests, you'll learn your health risks and how to prevent them.
Continue to Shop
[1] Basal cell carcinoma, European Skin Cancer Foundation, http://www.escf-network.eu/en/patients/skin-cancer/basal-cell-carcinoma.html
[2] McDaniel B, Badri T, Steele RB. Basal Cell Carcinoma. [Updated 2022 Sep 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482439/
[3] Pellegrini C, Maturo MG, Di Nardo L, Ciciarelli V, Gutiérrez García-Rodrigo C, Fargnoli MC. Understanding the Molecular Genetics of Basal Cell Carcinoma. Int J Mol Sci. 2017;18(11):2485. doi:10.3390/ijms18112485
[4] Nawrocka PM, Galka-Marciniak P, Urbanek-Trzeciak MO, et al. Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants. Front Oncol. 2021;11. Accessed January 2, 2023. https://www.frontiersin.org/articles/10.3389/fonc.2021.752579
[5] Dika E, Scarfì F, Ferracin M, et al. Basal Cell Carcinoma: A Comprehensive Review. Int J Mol Sci. 2020;21(15):5572. doi:10.3390/ijms21155572
[6] Hoashi T, Kanda N, Saeki H. Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma. Int J Mol Sci. 2022;23(19):11968. doi:10.3390/ijms231911968
[7] Page ML, Vance EL, Cloward ME, et al. The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores. Commun Biol. 2022;5(1):899. doi:10.1038/s42003-022-03795-x
[8] Basal cell carcinoma Warning signs, Skin Cancer Foundation, (skincancer.org), https://www.skincancer.org/skin-cancer-information/basal-cell-carcinoma/bcc-warning-signs-images/
[9] Basal cell carcinoma Treatment, Skin Cancer Foundation, (skincancer.org), https://www.skincancer.org/skin-cancer-information/basal-cell-carcinoma/bcc-treatment-options/
[10] Can Basal and Squamous Cell Skin Cancers Be Prevented?, (cancer.org),
https://www.cancer.org/cancer/basal-and-squamous-cell-skin-cancer/causes-risks-prevention/prevention.html
[11] Starr P. Oral Nicotinamide Prevents Common Skin Cancers in High-Risk Patients, Reduces Costs. Am Health Drug Benefits. 2015;8(Spec Issue):13-14.